U.S. stocks on the move: WhiteHawk, Mirum Pharmaceuticals, Nvidia
SPY•U.S. stock index futures fell after President Donald Trump rejected an Iranian proposal to end the conflict, pushing crude prices higher and rekindling inflation concerns. WhiteHawk gained on a $1.05 million debt facility, Mirum rose after an FDA nod for a rare bone disorder drug, and Nvidia gained after boosting its buyback by $150 billion.
1. Market backdrop
U.S. stock index futures dropped on Monday after President Donald Trump rejected an Iranian proposal to end the conflict. Crude prices spiked, rekindling inflation concerns and driving Treasury yields higher.
2. Company moves
WhiteHawk Therapeutics gained after entering a $1.05 million debt facility. Mirum Pharmaceuticals rose after an FDA nod for a rare bone disorder drug, while Nvidia gained after boosting its buyback by $150 billion. Tesla fell after JPMorgan cut its price target and lowered Q3 delivery estimates; Roblox shares fell 3% after Jefferies downgraded the company to “underperform.”
3. Other movers
U.S.-listed gold miners fell as bullion slipped, and silver miners fell on higher oil prices. Kodiak Sciences rose after its eye-disease drugs met trial goals, MediciNova fell after its fatty liver drug missed significance on blood-fat reduction, and Snowflake dropped on plans for a $3.5 billion, 0% convertible debt sale.
